Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic identification of mutations and copy number alterations associated with cancer patient prognosis
Authors
Keywords
-
Journal
eLife
Volume 7, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2018-12-11
DOI
10.7554/elife.39217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic and Functional Approaches to Understanding Cancer Aneuploidy
- (2018) Alison M. Taylor et al. CANCER CELL
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- A male and female RNA marker to infer sex in forensic analysis
- (2017) M. van den Berge et al. Forensic Science International-Genetics
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Widespread Post-transcriptional Attenuation of Genomic Copy-Number Variation in Cancer
- (2017) Emanuel Gonçalves et al. Cell Systems
- Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations
- (2016) David M. Roy et al. CANCER CELL
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Overtreatment in cancer – is it a problem?
- (2016) Jaimin R Bhatt et al. EXPERT OPINION ON PHARMACOTHERAPY
- OUP accepted manuscript
- (2016) NUCLEIC ACIDS RESEARCH
- A pan-cancer analysis of prognostic genes
- (2016) Jordan Anaya et al. PeerJ
- Lollipops in the Clinic: Information Dense Mutation Plots for Precision Medicine
- (2016) Jeremy J. Jay et al. PLoS One
- PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
- (2015) Chiya Oshiro et al. BREAST CANCER RESEARCH AND TREATMENT
- Does CDKN2A loss predict palbociclib benefit?
- (2015) J. Gao et al. Current Oncology
- Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
- (2015) Joann G. Elmore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Short- and long-term effects of chromosome mis-segregation and aneuploidy
- (2015) Stefano Santaguida et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy
- (2015) Mirko Marabese et al. Oncotarget
- Next-generation sequencing to guide cancer therapy
- (2015) Jeffrey Gagan et al. Genome Medicine
- Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
- (2015) Kasthuri Kannan et al. Oncotarget
- Focal chromosomal copy number aberrations in cancer—Needles in a genome haystack
- (2014) Oscar Krijgsman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
- (2014) Ewelina Nalejska et al. Molecular Diagnosis & Therapy
- Biomarker Validation: Common Data Analysis Concerns
- (2014) J. E. Ensor ONCOLOGIST
- Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis
- (2014) Bo Pang et al. Scientific Reports
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
- (2013) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
- (2013) Teresa Davoli et al. CELL
- Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma
- (2013) I. I. Wistuba et al. CLINICAL CANCER RESEARCH
- Overdiagnosis and Overtreatment in Cancer
- (2013) Laura J. Esserman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glioblastoma Cells Containing Mutations in the Cohesin Component STAG2 Are Sensitive to PARP Inhibition
- (2013) M. L. Bailey et al. MOLECULAR CANCER THERAPEUTICS
- Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
- (2013) Jong-Mu Sun et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy
- (2012) Ji-lin Guan et al. ANNALS OF SURGICAL ONCOLOGY
- Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
- (2012) Jing Shi et al. BMC CANCER
- Is DCIS Breast Cancer, and How Do I Treat it?
- (2012) N. Bijker et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Prognostic value ofTP53,KRASandEGFRmutations in nonsmall cell lung cancer: the EUELC cohort
- (2012) Chiara Scoccianti et al. EUROPEAN RESPIRATORY JOURNAL
- Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells
- (2012) Silvia Stingele et al. Molecular Systems Biology
- A novel retinoblastoma therapy from genomic and epigenetic analyses
- (2012) Jinghui Zhang et al. NATURE
- Absolute quantification of somatic DNA alterations in human cancer
- (2012) Scott L Carter et al. NATURE BIOTECHNOLOGY
- Cell Cycle Gene Networks Are Associated with Melanoma Prognosis
- (2012) Li Wang et al. PLoS One
- Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential
- (2012) N. L. Solimini et al. SCIENCE
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- The aneuploidy paradox: costs and benefits of an incorrect karyotype
- (2011) Jason M. Sheltzer et al. TRENDS IN GENETICS
- International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data
- (2011) J. Zhang et al. Database-The Journal of Biological Databases and Curation
- Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
- (2011) David Venet et al. PLoS Computational Biology
- Overall Survival: Still the Gold Standard
- (2010) James J. Driscoll et al. CANCER JOURNAL
- Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer
- (2010) Stefan S. Bozhanov et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: A prospective translational study on a uniformly treated cohort of adult patients
- (2010) Mallavarapu R. Srividya et al. NEUROPATHOLOGY
- Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
- (2009) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAFMutation in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists
- (2008) Jonathan D Mosley et al. BMC Medical Genomics
- Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells
- (2008) B. R. Williams et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started